SI-Bone revenue up 22% in Q1, new CEO takes charge: 6 notes

Sacropelvic device company SI-Bone reported May 3 that first-quarter revenue increased 22 percent year over year to $20.4 million.

Advertisement

Six notes:

1. U.S. revenue in the first quarter increased 23 percent year over year to $18.8 million.

2. First-quarter operating expenses rose to $29.8 million, an 11 percent increase compared to the prior year period. The company attributed the spike to higher sales and marketing expenses due to increased hiring, research and development expenses and increased stock-based compensation expense.

3. Net loss for the first quarter was $12.2 million compared to $12.8 million in the first quarter of 2020.

4. As of March 31, cash and marketable securities were $185.1 million, and long-term borrowings were $39.5 million.

5. SI-Bone launched iFuse-Torq, a 3D-printed implant designed for pelvic trauma and minimally invasive sacroiliac joint fusion.

6. Laura Francis, SI-Bone’s former CFO and COO, assumed the role of CEO from Jeff Dunn, who will remain with the company as executive chair.

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.